Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Anesteziol Reanimatol ; (1): 10-3, 2010.
Artigo em Russo | MEDLINE | ID: mdl-20564931

RESUMO

The investigators made a prospective analysis of the specific features of anesthesias with sevoflurane and halothane in 70 children aged 1 to 11 years with systemic surgical diseases and assessed their physical status as ASA Class I. The anesthetics sevoflurane, 3.1 +/- 0.7 MAC, and halothane, 2.4 +/- 0.3 MAC, were used to induce anesthesia. Sevoflurane, 1.6 +/- 0.6 MAC, and halothane, 1.5 +/- 0.4 MAC, were employed to maintain anesthesia. In children, sevoflurane anesthesia induction and emergence occurred by 49% more rapidly (p < 0.001) than halothane use (the time of induction 2.9 +/- 0.7 min for sevoflurane versus 5.7 +/- 0.5 min for halothane; that of consciousness recovery 3.6 +/- 0.7 min versus 7.0 +/- 1.2 min). After halothane anesthesia anesthesia, there was a significant reduction in mean blood pressure (BP) by 24.5% as compared with the baseline values (p < 0.001). Sevoflurane use demonstrated a significantly less reduction in systolic BP--by 10.2% of the baseline value (p < 0.001). In both groups after induction, there was a decrease in tidal volume, but minute volume was insignificantly lower due to higher respiration rate. The level of blood oxygenation was stable (SpO2 97-99%) in both groups during all observational stages. No severe complications were recorded in both groups during anesthesia. However, mild or moderate complications were twice fewer in the sevoflurane group.


Assuntos
Anestesia por Inalação/métodos , Anestésicos Inalatórios/uso terapêutico , Halotano/uso terapêutico , Éteres Metílicos/uso terapêutico , Período de Recuperação da Anestesia , Anestésicos Inalatórios/administração & dosagem , Anestésicos Inalatórios/efeitos adversos , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Halotano/administração & dosagem , Halotano/efeitos adversos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Lactente , Masculino , Éteres Metílicos/administração & dosagem , Éteres Metílicos/efeitos adversos , Respiração/efeitos dos fármacos , Sevoflurano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA